查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1604719

首頁 藥物濫用檢測市場：依產品類型、藥物、通路 - 2025-2030 年全球預測

At-home Drug of Abuse Testing Market by Product (Blood-Based Testing Kits, Breathalyzer Testing Kits, Hair-Based Testing Kits), Test Type (Cups, Strips), Drug, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年家庭藥物濫用檢測市場價值為26.8億美元，預計到2024年將達到28.8億美元，複合年成長率為7.25%，預計到2030年將達到43.8億美元。

家庭藥物濫用檢測是指市售的套件，可以讓個人方便檢測非法藥物。對於及早發現和預防藥物濫用、促進及時介入和護理至關重要。這些測試適用於家庭、職場、復健中心、執法機構等，以確保合規性和安全性。主要最終用戶包括父母、雇主、緩刑官員、醫療保健提供者等，他們優先考慮保密和快速結果。藥物濫用現象的日益普遍、人們對藥物測試重要性的認知不斷提高以及提高準確性和易用性的測試技術的進步推動了市場的成長。此外，大麻在各個地區日益合法化正在推動對 THC 特定測試產品的需求，創造利潤豐厚的機會。然而，監管不確定性、結果準確性、對誤報的擔憂以及某些藥物的檢測限制等挑戰阻礙了採用。此外，分散的法規環境可能會給製造商帶來合規障礙。透過整合行動應用程式等數位技術並提供即時結果和指導，存在改善用戶體驗的潛在機會。此外，保持不同物質和藥物準確性的多藥物檢測套組的創新預計將擴大市場基礎。此外，對生物感測器技術和非侵入性測試方法的研究可能會帶來重要的創新。市場競爭日益激烈，但市場分散，許多公司進入市場，從成熟的診斷公司到利基新興企業。為了取得成功，公司必須專注於分銷和意識計劃的策略夥伴關係關係，以教育消費者有關家庭檢測套組的重要性和可靠性。與監管機構合作確保遵守標準對於克服重大障礙至關重要。公司應該利用巨量資料分析來追蹤使用模式並改善產品開發，以有效回應新的消費者需求和偏好。

主要市場統計
基準年[2023] 26.8億美元
預計年份 [2024] 28.8億美元
預測年份 [2030] 43.8億美元
複合年成長率（%） 7.25%

市場動態：快速發展的家庭藥物濫用檢測市場的關鍵市場洞察

供需的動態交互作用正在改變家庭藥物濫用檢測市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 非法藥物的使用和生產增加
    • 政府努力減少藥物濫用
    • 藥品生產擴大需要有效的檢測措施
  • 市場限制因素
    • 無法檢測少量特殊藥物的測試產品
  • 市場機會
    • 新型家用藥物濫用檢測設備的技術進步與開發
    • 家庭藥物濫用檢測設備研發活動的投資
  • 市場挑戰
    • 對家用藥物濫用檢測設備缺乏認知

波特五力：駕馭家庭藥物濫用檢測市場的策略工具

波特的五力框架是了解家庭藥物濫用測試市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解家庭藥物濫用檢測市場的外部影響

外部宏觀環境因素在塑造家庭藥物濫用檢測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解家庭藥物濫用檢測市場的競爭格局

家庭藥物濫用測試市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣家庭藥物濫用測試市場供應商的績效評估

FPNV 定位矩陣是評估居家藥物濫用測試市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製家庭藥物濫用檢測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對家庭藥物濫用檢測市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 非法藥物的使用和生產增加
      • 政府努力減少藥物濫用
      • 擴大藥品生產需要有效的檢測措施
    • 抑制因素
      • 產品無法檢測微量特殊藥物
    • 機會
      • 技術進步與新型家用藥物濫用檢測設備的開發
      • 家庭藥物濫用檢測設備研發活動的投資
    • 任務
      • 對家用藥物濫用檢測設備缺乏認知
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章家庭藥物濫用檢測市場：依產品

  • 血液檢測套組
  • 呼氣分析儀檢測套組
  • 頭髮檢測套組
  • 唾液檢測套組
  • 尿液檢查套件

第7章按測試類型分類的家庭藥物濫用測試市場

  • 杯子
  • 條

第8章 家庭藥物濫用檢測市場（按藥物）

  • 酒精
  • 安非他命
  • 苯二氮平類
  • 古柯鹼
  • 大麻
  • 鴉片類藥物

第9章家庭藥物濫用檢測市場：依分銷管道分類

  • 離線
  • 線上

第10章美洲家庭藥物濫用檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太家庭藥物濫用檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲/中東/非洲家庭藥物濫用檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • Accuquik by AdvaCare Pharma USA
  • Atlas Medical GmbH
  • BioMerieux, Inc.
  • Biopanda Reagents Ltd.
  • BTNX Inc.
  • Confirm BioSciences
  • Dragerwerk AG & Co. KGaA
  • Exploro Products
  • Identify Diagnostics by Medical Distribution Group, Inc.
  • Innovatek Medical Inc.
  • InTec Products, Inc.
  • Laboratory Corporation of America Holdings
  • McKesson Medical-Surgical
  • MyDiagnostics by Phyteos Helath Systems Inc.
  • myLAB Box Inc.
  • OraSure Technologies, Inc.
  • Phamatech Inc. by Caris Life Sciences
  • Psychemedics Corporation
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • UCP Biosciences Inc.
  • Vitrosens Biotechnology
  • Xiamen Boson Biotech Co., Ltd.
Product Code: MRR-B168537784E8

The At-home Drug of Abuse Testing Market was valued at USD 2.68 billion in 2023, expected to reach USD 2.88 billion in 2024, and is projected to grow at a CAGR of 7.25%, to USD 4.38 billion by 2030.

At-home drug of abuse testing refers to commercially available kits enabling individuals to test for illicit drugs privately and conveniently. They are crucial for early detection and prevention of drug misuse, facilitating immediate intervention and care. These tests find applications in households, workplaces, rehabilitation centers, and law enforcement to ensure compliance and safety. Key end-users include parents, employers, probation officers, and healthcare providers prioritizing confidentiality and rapid results. Market growth is fueled by the rising prevalence of drug abuse, increasing awareness about drug testing's importance, and advancements in testing technology which have enhanced accuracy and ease of use. Moreover, the expanding legality of cannabis in various regions stirs demand for THC-specific testing products, presenting lucrative opportunities. Nonetheless, challenges like regulatory uncertainties, concerns over result accuracy, false positives, and specific drugs' detection limitations hinder adoption. A fragmented regulatory environment across regions may also create compliance hurdles for manufacturers. The potential opportunity lies in integrating digital technologies, like mobile apps, to offer real-time results and guidance, improving user experience. Innovating multi-drug testing kits that maintain precision across different substances and drugs will also widen market reach. Furthermore, research into biosensor technology and non-invasive testing methods could yield significant innovations. The nature of the market is competitive yet fragmented with numerous players ranging from established diagnostics companies to niche startups. To thrive, companies must focus on strategic partnerships for distribution and awareness programs to educate consumers on the importance and reliability of at-home testing kits. Collaboration with regulatory bodies to ensure standards compliance will be vital in surpassing significant barriers. Businesses should leverage big data analytics to track usage patterns and improve product developments, ensuring they meet emerging consumer needs and preferences effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 2.68 billion
Estimated Year [2024] USD 2.88 billion
Forecast Year [2030] USD 4.38 billion
CAGR (%) 7.25%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving At-home Drug of Abuse Testing Market

The At-home Drug of Abuse Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing use and production of illicit drugs
    • Government initiatives to reduce drug abuse
    • Expansion of drug production necessitates effective test measures
  • Market Restraints
    • Inability of testing products to detect small amounts of special drugs
  • Market Opportunities
    • Technological advancement and development of novel at-home drug of abuse testing devices
    • Investment in R&D activities for at-home drug of abuse testing devices
  • Market Challenges
    • Lack of awareness of at-home drug of abuse testing devices

Porter's Five Forces: A Strategic Tool for Navigating the At-home Drug of Abuse Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the At-home Drug of Abuse Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the At-home Drug of Abuse Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the At-home Drug of Abuse Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the At-home Drug of Abuse Testing Market

A detailed market share analysis in the At-home Drug of Abuse Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the At-home Drug of Abuse Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the At-home Drug of Abuse Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the At-home Drug of Abuse Testing Market

A strategic analysis of the At-home Drug of Abuse Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the At-home Drug of Abuse Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuBioTech Co., Ltd., Accuquik by AdvaCare Pharma USA, Atlas Medical GmbH, BioMerieux, Inc., Biopanda Reagents Ltd., BTNX Inc., Confirm BioSciences, Dragerwerk AG & Co. KGaA, Exploro Products, Identify Diagnostics by Medical Distribution Group, Inc., Innovatek Medical Inc., InTec Products, Inc., Laboratory Corporation of America Holdings, McKesson Medical-Surgical, MyDiagnostics by Phyteos Helath Systems Inc., myLAB Box Inc., OraSure Technologies, Inc., Phamatech Inc. by Caris Life Sciences, Psychemedics Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., UCP Biosciences Inc., Vitrosens Biotechnology, and Xiamen Boson Biotech Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the At-home Drug of Abuse Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Blood-Based Testing Kits, Breathalyzer Testing Kits, Hair-Based Testing Kits, Saliva-Based Testing Kits, and Urine-Based Testing Kits.
  • Based on Test Type, market is studied across Cups and Strips.
  • Based on Drug, market is studied across Alcohol, Amphetamines, Benzodiazepines, Cocaine, Marijuana, and Opioids.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing use and production of illicit drugs
      • 5.1.1.2. Government initiatives to reduce drug abuse
      • 5.1.1.3. Expansion of drug production necessitates effective test measures
    • 5.1.2. Restraints
      • 5.1.2.1. Inability of testing products to detect small amounts of special drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement and development of novel at-home drug of abuse testing devices
      • 5.1.3.2. Investment in R&D activities for at-home drug of abuse testing devices
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness of at-home drug of abuse testing devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. At-home Drug of Abuse Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Blood-Based Testing Kits
  • 6.3. Breathalyzer Testing Kits
  • 6.4. Hair-Based Testing Kits
  • 6.5. Saliva-Based Testing Kits
  • 6.6. Urine-Based Testing Kits

7. At-home Drug of Abuse Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Cups
  • 7.3. Strips

8. At-home Drug of Abuse Testing Market, by Drug

  • 8.1. Introduction
  • 8.2. Alcohol
  • 8.3. Amphetamines
  • 8.4. Benzodiazepines
  • 8.5. Cocaine
  • 8.6. Marijuana
  • 8.7. Opioids

9. At-home Drug of Abuse Testing Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Americas At-home Drug of Abuse Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific At-home Drug of Abuse Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa At-home Drug of Abuse Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AccuBioTech Co., Ltd.
  • 3. Accuquik by AdvaCare Pharma USA
  • 4. Atlas Medical GmbH
  • 5. BioMerieux, Inc.
  • 6. Biopanda Reagents Ltd.
  • 7. BTNX Inc.
  • 8. Confirm BioSciences
  • 9. Dragerwerk AG & Co. KGaA
  • 10. Exploro Products
  • 11. Identify Diagnostics by Medical Distribution Group, Inc.
  • 12. Innovatek Medical Inc.
  • 13. InTec Products, Inc.
  • 14. Laboratory Corporation of America Holdings
  • 15. McKesson Medical-Surgical
  • 16. MyDiagnostics by Phyteos Helath Systems Inc.
  • 17. myLAB Box Inc.
  • 18. OraSure Technologies, Inc.
  • 19. Phamatech Inc. by Caris Life Sciences
  • 20. Psychemedics Corporation
  • 21. Siemens Healthineers AG
  • 22. Thermo Fisher Scientific Inc.
  • 23. UCP Biosciences Inc.
  • 24. Vitrosens Biotechnology
  • 25. Xiamen Boson Biotech Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. AT-HOME DRUG OF ABUSE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. AT-HOME DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. AT-HOME DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AT-HOME DRUG OF ABUSE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AT-HOME DRUG OF ABUSE TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY BLOOD-BASED TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY BREATHALYZER TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR-BASED TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA-BASED TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY URINE-BASED TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CUPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STRIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ALCOHOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY AMPHETAMINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COCAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MARIJUANA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 194. AT-HOME DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 195. AT-HOME DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023